Analyst Barry Oxford of Colliers Securities maintained a Buy rating on American Healthcare REIT, Inc. (AHR – Research Report), boosting the price target to $40.00.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Barry Oxford has given his Buy rating due to a combination of factors including American Healthcare REIT’s impressive financial performance and strategic acquisitions. The company reported a strong same-store net operating income (NOI) growth of 15.1% year-over-year, driven by significant gains in their “SHOP” properties and integrated senior health campuses. This robust performance is further supported by the company’s ability to exceed earnings expectations, with normalized funds from operations (FFO) coming in higher than consensus estimates.
Additionally, the company has raised its guidance for 2025, reflecting confidence in continued strong operating results. The acquisition of the remaining minority stake in Trilogy and strategic property dispositions and acquisitions, including a significant SHOP property, demonstrate the company’s proactive management and growth strategy. With over $300 million available for future acquisitions, American Healthcare REIT is well-positioned for further expansion, supporting Barry Oxford’s optimistic outlook and Buy rating.
In another report released today, Citizens JMP also maintained a Buy rating on the stock with a $40.00 price target.